Document is current
Any future updates will be listed below
-
Authors
Prazak, Josef https://orcid.org/0000-0002-4515-3399
Irincheeva, Irina
Llewelyn, Martin J.
Stolz, Daiana
García de Guadiana Romualdo, Luis
Graf, Rolf
Reding, Theresia
Klein, Holger J.
Eggimann, Philippe
Que, Yok-Ai
-
Funding
Funding for this research was provided by:
Unrestricted Institutional Funds
- License Information
-
More Information
Article History
Received: 16 February 2021
Accepted: 19 May 2021
First Online: 28 May 2021
Declarations
:
: The Cantonal Ethical Committee of the State of Bern (#2018–01356) reviewed and approved the protocol of this systematic review and meta-analysis in 2018; the respective ethical committees approved all specific studies.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at and declare: no support from any organization for the submitted work. RG has received research grants from Gebert Rüf Foundation, in addition, Dr. Graf has a patent method for assaying sepsis and outcome in humans by detection of PSP/reg licensed to LASCCO. DS reports grants from Astra-Zeneca AG, Curetis AG, Boston Scientific, other from Astra-Zeneca AG, Novartis AG, GSK AG, Roche AG, Zambon, Pfizer and Schwabe Pharma AG, Vifor AG, outside the submitted work. In addition, Dr. Stolz has a patent PSP for COPD/VAP. PE has received research grants from Abionic outside the submitted work.
